Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway

Abstract Background The upregulation of interferon (IFN)-stimulated genes induced by type I IFNs (namely type I IFN signature) in rheumatoid arthritis (RA) patients had implications in early diagnosis and prediction of therapy responses. However, factors that modulate the type I IFN signature in RA...

Full description

Bibliographic Details
Main Authors: Yu Du, Ran Cui, Na Tian, Miao Chen, Xian-Long Zhang, Sheng-Ming Dai
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-022-02880-0
_version_ 1811215714496806912
author Yu Du
Ran Cui
Na Tian
Miao Chen
Xian-Long Zhang
Sheng-Ming Dai
author_facet Yu Du
Ran Cui
Na Tian
Miao Chen
Xian-Long Zhang
Sheng-Ming Dai
author_sort Yu Du
collection DOAJ
description Abstract Background The upregulation of interferon (IFN)-stimulated genes induced by type I IFNs (namely type I IFN signature) in rheumatoid arthritis (RA) patients had implications in early diagnosis and prediction of therapy responses. However, factors that modulate the type I IFN signature in RA are largely unknown. In this study, we aim to explore the involvement of VGLL3, a homologue of the vestigial-like gene in Drosophila and a putative regulator of the Hippo pathway, in the modulation of type I IFN signature in the fibroblast-like synoviocytes (FLS) of RA patients. Methods FLS were isolated from RA and osteoarthritis (OA) patients. Expression of VGLL3 in the synovial tissues and FLS was analyzed by immunohistochemistry and PCR. RNA sequencing was performed in RA-FLS upon VGLL3 overexpression. The expression of IFN-stimulated genes was examined by PCR and Western blotting. Results VGLL3 was upregulated in the RA synovium and RA-FLS compared to OA. Overexpression of VGLL3 promoted the expression of IFN-stimulated genes in RA-FLS. The expression of STAT1 and MX1 was also upregulated in RA synovium compared to OA and was associated with the expression of VGLL3 in RA and OA patients. VGLL3 promoted the IRF3 activation and IFN-β1 expression in RA-FLS. Increased IFN-β1 induced the expression of IFN-stimulated genes in RA-FLS in an autocrine manner. VGLL3 also modulated the expression of the Hippo pathway molecules WWTR1 and AMOTL2, which mediated the regulation of IRF3 activation and IFN-β1 production by VGLL3 in RA-FLS. Conclusions VGLL3 drives the IRF3-induced IFN-β1 expression in RA-FLS by inhibiting WWTR1 expression and subsequently promotes the type I IFN signature expression in RA-FLS through autocrine IFN-β1 signaling.
first_indexed 2024-04-12T06:28:12Z
format Article
id doaj.art-734a0ec6fe9c4ce3a8e3e193d3ab8e06
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-04-12T06:28:12Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-734a0ec6fe9c4ce3a8e3e193d3ab8e062022-12-22T03:44:06ZengBMCArthritis Research & Therapy1478-63622022-08-0124111210.1186/s13075-022-02880-0Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathwayYu Du0Ran Cui1Na Tian2Miao Chen3Xian-Long Zhang4Sheng-Ming Dai5Department of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalDepartment of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalDepartment of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalDepartment of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalDepartment of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalDepartment of Rheumatology and Immunology, Shanghai Jiao Tong University Affiliated Sixth People’s HospitalAbstract Background The upregulation of interferon (IFN)-stimulated genes induced by type I IFNs (namely type I IFN signature) in rheumatoid arthritis (RA) patients had implications in early diagnosis and prediction of therapy responses. However, factors that modulate the type I IFN signature in RA are largely unknown. In this study, we aim to explore the involvement of VGLL3, a homologue of the vestigial-like gene in Drosophila and a putative regulator of the Hippo pathway, in the modulation of type I IFN signature in the fibroblast-like synoviocytes (FLS) of RA patients. Methods FLS were isolated from RA and osteoarthritis (OA) patients. Expression of VGLL3 in the synovial tissues and FLS was analyzed by immunohistochemistry and PCR. RNA sequencing was performed in RA-FLS upon VGLL3 overexpression. The expression of IFN-stimulated genes was examined by PCR and Western blotting. Results VGLL3 was upregulated in the RA synovium and RA-FLS compared to OA. Overexpression of VGLL3 promoted the expression of IFN-stimulated genes in RA-FLS. The expression of STAT1 and MX1 was also upregulated in RA synovium compared to OA and was associated with the expression of VGLL3 in RA and OA patients. VGLL3 promoted the IRF3 activation and IFN-β1 expression in RA-FLS. Increased IFN-β1 induced the expression of IFN-stimulated genes in RA-FLS in an autocrine manner. VGLL3 also modulated the expression of the Hippo pathway molecules WWTR1 and AMOTL2, which mediated the regulation of IRF3 activation and IFN-β1 production by VGLL3 in RA-FLS. Conclusions VGLL3 drives the IRF3-induced IFN-β1 expression in RA-FLS by inhibiting WWTR1 expression and subsequently promotes the type I IFN signature expression in RA-FLS through autocrine IFN-β1 signaling.https://doi.org/10.1186/s13075-022-02880-0Rheumatoid arthritisInterferon betaType I interferon signatureHippo pathway
spellingShingle Yu Du
Ran Cui
Na Tian
Miao Chen
Xian-Long Zhang
Sheng-Ming Dai
Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
Arthritis Research & Therapy
Rheumatoid arthritis
Interferon beta
Type I interferon signature
Hippo pathway
title Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
title_full Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
title_fullStr Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
title_full_unstemmed Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
title_short Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway
title_sort regulation of type i interferon signature by vgll3 in the fibroblast like synoviocytes of rheumatoid arthritis patients via targeting the hippo pathway
topic Rheumatoid arthritis
Interferon beta
Type I interferon signature
Hippo pathway
url https://doi.org/10.1186/s13075-022-02880-0
work_keys_str_mv AT yudu regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway
AT rancui regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway
AT natian regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway
AT miaochen regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway
AT xianlongzhang regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway
AT shengmingdai regulationoftypeiinterferonsignaturebyvgll3inthefibroblastlikesynoviocytesofrheumatoidarthritispatientsviatargetingthehippopathway